Initiation of Phase 2 Clinical Trial Expected in CY Q1 2022
 |
MELBOURNE, Australia, Dec. 14, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced that the New Zealand...
Hashtag.net.au
For many Australians living with significant disability, the question of where to live — and how to live there safely and comfortably — is one of the most important and most complex they will ever f...
Hashtag.net.au
If you're running a construction site, a civil project, or a trade-based operation anywhere in Australia, first aid preparedness probably sits somewhere near the bottom of your planning checklist — ...
Hashtag.net.au
Imagine waking up each morning feeling truly refreshed, without the usual aches and stiffness. For many, a traditional flat bed can fall short in providing the tailored support needed for optimal rest...